1-[2-(substituted vinyl)]-3,4-dihydro-5H-2,3-benzodiazepine derivatives

New 1-[2-(substituted vinyl)]-3,4-dihidro-5 H -2,3-benzodiazepine derivatives correspond to the general formula (I), wherein R represents hydrogen or C 1-4 alkanoyl, R 1 stands for phenyl optionally carrying 1-3 identical or different substituent(s) selected from halogen, nitro, amino, C 1-4 alkylam...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GYOERGYNE MATE, FERENC ANDRASI, IMRE MORAVCSIK, ESZTER SZENTKUTI, PAL VAGO, EDIT HORVATH, GYOERGY SOMOGYI, ANNA BAKONYI, GABOR ZOLYOMI, ERZSEBET BIRKAS FAIGLNE, TAMAS HAMORI, PETER BOTKA, GABOR GIGLER, JENO KOROSI, JOSZEF REITER, PAL BERZSENYI, KATALIN HORVATH, ISTVAN GYERTYAN
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:New 1-[2-(substituted vinyl)]-3,4-dihidro-5 H -2,3-benzodiazepine derivatives correspond to the general formula (I), wherein R represents hydrogen or C 1-4 alkanoyl, R 1 stands for phenyl optionally carrying 1-3 identical or different substituent(s) selected from halogen, nitro, amino, C 1-4 alkylamino, di(C 1-4 alkyl)-amino, C 1-4 alkanoylamino, C 1-4 alkyl, C 1-4 alkoxy, methylenedioxy and hydroxy; or naphthyl optionally carrying a substituent selected hydroxy, C 1-4 alkyl and C 1-4 alkoxy; R 2 stands for hydrogen or C 1-4 alkyl; R 3 and R 4 are independently C 1-4 alkyl, or R 3 and R 4 together form methylene. The new compounds affect the central nervous system and can be used to advantage in the therapy.